Renal Mass Biopsy is Associated With Fewer Radical Nephrectomies for Benign or Indolent Disease, Particularly for ...
This is from the cancernetwork.com
At the 2024 Kidney Cancer Research Summit (KCRS), CancerNetwork® spoke with ...
Sex-specific survival gene mutations are discovered as clinical predictors of clear cell renal cell carcinoma
The ...
A new positron emission computed tomography (PET) agent achieves “exceptional” imaging quality of lesions in ...
Massive study identifies new biomarkers for renal cancer subtypes, improving diagnosis ...
Recently published in the New England Journal of Medicine, findings from the pivotal phase 3 trial, KEYNOTE-564, ...
NEW Kidney Cancer UK Patient Survey 2023 Report FINDS KIDNEY CANCER PATIENTS ARE BEING MISDIAGNOSED, CONFUSED ...
Kidney Cancer UK is delighted to present our first Webinar for 2024 on Tuesday January 16th at 6pm, ‘Counselling – ...
Merck partners with HiberCell for Phase Ib renal carcinoma trial
The Phase Ib trial will evaluate the ...
Living with a rare disease can be challenging enough, especially when it impacts you physically. But for those ...
A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup of patients with clear-cell ...
The drug response predictor companion diagnostic for dovinitib (DRP-Dovitinib) demonstrates potential to identify ...